Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (UNAUDITED)

v3.22.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Series A Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Treasury Stock
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Non- Controlling Interest
Balance, shares at Dec. 31, 2020       194,204,459     2,308,412      
Balance, amount at Dec. 31, 2020 $ 59,130 $ (12)   $ 218 $ 275,060 $ (1,071) $ (808) $ (219,803) $ 1,059 $ 4,463
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock compensation - directors (in shares)       541,666            
Stock compensation - directors 122     $ 1 121          
Stock compensation - services expense (in shares)       322,947            
Stock compensation - services expense 32       32          
Stock option exercises (in shares)       1,226,230            
Stock option exercises 0     $ 1 (1)          
Acquisition of A shares (in shares)       16,485,714     8      
Acquisition of A shares 5,889     $ 16 5,873          
Debt conversion - common stock (in shares)       20,391,774            
Debt conversion - common stock 4,009     $ 20 3,989          
Warrants issued to Dominion 5,978       5,978          
Stock option expense 244       244          
Less: Income (loss) attributable to non-controlling interest from discontinued operations 381                 381
Net loss attributable to Unrivaled Brands, Inc. (12,077)             (12,077)    
Balance, shares at Mar. 31, 2021       233,172,790     2,308,420      
Balance, amount at Mar. 31, 2021 63,696     $ 256 290,225   $ (808) (230,821)   4,844
Balance, shares at Dec. 31, 2021     8 496,237,883     2,308,420      
Balance, amount at Dec. 31, 2021 $ 146,487     $ 521 392,930   $ (808) (250,015)   3,859
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Warrants exercise (in shares) 4,759,708     4,759,708            
Warrants exercise $ 0     $ 5 (5)          
Stock compensation - employees (in shares)       900,000            
Stock compensation - employees 182     $ 1 181          
Stock compensation - directors (in shares)       683,332            
Stock compensation - directors 184     $ 1 183          
Stock option exercises (in shares)       146,212            
Debt conversion - common stock (in shares)       294,452            
Debt conversion - common stock 75       75          
Stock issued for cash (in shares)       25,000,000            
Stock issued for cash 4,375     $ 24 4,351          
Stock option expense 1,821       1,821          
Less: Income (loss) attributable to non-controlling interest from discontinued operations 275                 275
Net loss attributable to Unrivaled Brands, Inc. (8,873)             (8,873)    
Balance, shares at Mar. 31, 2022     8 528,021,587     2,308,420      
Balance, amount at Mar. 31, 2022 $ 144,526     $ 552 $ 399,536   $ (808) $ (258,888)   $ 4,134